Accordingly, we speculated that FCRLB may serve as an oncogene that influences the prognosis of patients with CRC through these common biological pathways (Li et al., 2014; Nakamura et al., 2018; Ievgenia and Cédric, 2019; Patra et al., 2021). The gene discussed is FCRLB; the disease is colorectal carcinoma.